Table 3.
Treatment received according to maximum level of respiratory support required.
| All Patients (n = 100) |
Invasive Mechanical Ventilation (n = 30) |
Non-Invasive Respiratory Support (n = 38) |
No Respiratory Support (n = 32) |
p | |
|---|---|---|---|---|---|
| Pharmacological Treatment | |||||
| Nebulised Bronchodilators | 100 (100) | 100 (100) | 100 (100) | 100 (100) | 1.000 |
| Corticosteroids | 95 (95) | 29 (97) | 36 (95) | 30 (94) | 0.593 |
| Antibiotics | 64 (64) | 23 (77) | 26 (68) | 14 (44) | 0.005 |
| Mucolytics | 27 (27) | 16 (53) | 8 (21) | 3 (9) | <0.001 |
| IV Magnesium | 96 (96) | 30 (100) | 35 (92) | 30 (94) | 0.125 |
| IV Aminophylline | 62 (62) | 24 (80) | 23 (61) | 15 (49) | 0.007 |
| IV Salbutamol | 28 (28) | 13 (43) | 6 (16) | 9 (28) | 0.012 |
| IV Adrenaline | 21 (21) | 17 (57) | 2 (5) | 2 (6) | <0.001 |
| IV Ketamine | 20 (20) | 17 (57) | 1 (3) | 2 (6) | <0.001 |
| Inhaled Isoflurane | 4 (4) | 4 (13) | 0 (0) | 0 (0) | 0.002 |
| First Respiratory Support | |||||
| HFNO | 23 (23) | 6 (20) | 17 (45) | 0 (0) | <0.001 |
| CPAP | 4 (4) | 1 (3) | 3 (8) | 0 (0) | 0.090 |
| NIV | 24 (24) | 6 (20) | 18 (47) | 0 (0) | <0.001 |
| IMV | 17 (17) | 17 (57) | 0 (0) | 0 (0) | <0.001 |
Abbreviations: HFNO, high-flow nasal oxygen; CPAP, continuous positive airway pressure; NIV, non-invasive ventilation; IMV, invasive mechanical ventilation. Footnotes: Categorical data are presented as number (percentage). We compared between groups using the Chi-squared test.